Lyhyt kuvaus
The synthesis device to be provided is appropriate for radiopharmaceutical production according to cGMP (current good manufacturing practice) regulations. The device is used for developing GMP synthesis sequences for new radiopharmaceutical candidates and is capable to utilize the typical PET-radionuclides (including 18F, 11C and radiometals) as starting materials.
The device must fulfill the obligatory criteria as expressed in Call for tenders. In addition, the suitability of the device is evaluated based on optional and/or desirable features the device may contain or be equipped with. These optional/desirable features are expressed in the Procurement object criteria.